REVIEW PAPER
Impact of heated tobacco products on health – a comparative analysis with traditional cigarettes
More details
Hide details
1
Internal Medicine, Pomeranian Medical University, Szczecin, Poland
2
Department of Internal Medicine, 109th Military Hospital SPZOZ, Szczecin, Poland
3
Department of Internal Medicine, Pomeranian Medical University, Szczecin, Poland
4
Department of Internal Medicine, University Clinical Hospital No. 2 Pomeranian Medical University, Szczecin, Poland
5
Department of Internal Medicine, University Clinical Hospital, Poznań, Poland
6
Department of Internal Medicine, Multispeciality Regional Hospital, Gorzów Wielkopolski, Poland
7
6th year medicine student, Pomeranian Medical University, Szczecin, Poland
8
Department of Internal Medicine, 4th Military Clinical Hospital, Wrocław, Poland
These authors had equal contribution to this work
Corresponding author
Aleksandra Dąbrowska
Internal Medicine, Pomeranian Medical University, Rybacka 1, 70-204, Szczecin, Poland
KEYWORDS
TOPICS
ABSTRACT
Introduction and objective:
Smoking is one of the most significant modifiable risk factors for many diseases and related deaths. In recent years, more and more people are seeking alternatives that allow them to quit smoking and improve their quality of life. One such alternative is Heat-Not-Burn Tobacco Products (HTPs), which have gained significant popularity among both smokers and non-smokers. Their impact on human health has not yet been thoroughly investigated. This review summarizes the current knowledge regarding the impact of these devices on human health.
Objective:
The aim of the study is to investigate the physiological and biochemical effects of HTP devices on human health, and to compare their impact relative to traditional cigarettes on the functions of the cardiovascular, respiratory, digestive, skeletal and urinary systems, oxidative stress, inflammatory state, and periodontal diseases.
Review Methods:
A review was performed of studies available on PubMed and Google Scholar
Summary:
The scientific research cited in the review confirms the negative impact of HTP devices on human health,
although clearly demonstrating that they represent a better alternative to traditional cigarettes. This is achieved through the reduction of harmful substance content in the inhaled aerosol, resulting in lower oxidative stress, inflammatory state, and intensity of many diseases affecting smokers.
ABBREVIATIONS
HTP- heated tobacco product CC- combustible cigarette COPD- chronic obstructive pulmonary disease HDL-C- high-density lipoprotein
REFERENCES (39)
1.
Wynder EL, Graham EA. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. J Am Med Assoc. 1950;143(4):329–336. doi:10.1001/jama.1950.02910390001001.
2.
Doll R, HILL AB. Smoking and carcinoma of the lung; preliminary report. Br Med J. 1950;2(4682):739–748. doi:10.1136/bmj.2.4682.739.
3.
Centers for Disease Control and Prevention (CDC). Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000–2004. MMWR Morb Mortal Wkly Rep. 2008;57(45):1226–1228.
4.
Ezzati M, Henley SJ, Thun MJ, Lopez AD. Role of smoking in global and regional cardiovascular mortality. Circulation. 2005;112(4):489–497. doi:10.1161/CIRCULATIONAHA.104.521708.
5.
Laniado-Laborín R. Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century. Int J Environ Res Public Health. 2009;6(1):209–224. doi:10.3390/ijerph6010209.
6.
Repace JL. The problem of passive smoking. Bull NY Acad Med. 1981;57(10):936–946.
8.
Lopez AA, Hiler M, Maloney S, Eissenberg T, Breland AB. Expanding clinical laboratory tobacco product evaluation methods to loose-leaf tobacco vaporizers. Drug Alcohol Depend. 2016;169:33–40. doi:10.1016/j.drugalcdep.2016.10.005.
9.
Glantz SA. PMI’s own in vivo clinical data on biomarkers of potential harm in Americans show that IQOS is not detectably different from conventional cigarettes. Tob Control. 2018;27(Suppl 1):s9-s12. doi:10.1136/tobaccocontrol-2018-054413.
10.
Mallock N, Böss L, Burk R, et al. Levels of selected analytes in the emissions of “heat not burn” tobacco products that are relevant to assess human health risks. Arch Toxicol. 2018;92(6):2145–2149. doi:10.1007/s00204-018-2215-y.
11.
Bekki K, Inaba Y, Uchiyama S, Kunugita N. Comparison of Chemicals in Mainstream Smoke in Heat-not-burn Tobacco and Combustion Cigarettes. J UOEH. 2017;39(3):201–207. doi:10.7888/juoeh.39.20.
12.
Biondi-Zoccai G, Sciarretta S, Bullen C, et al. Acute Effects of Heat-Not-Burn, Electronic Vaping, and Traditional Tobacco Combustion Cigarettes: The Sapienza University of Rome-Vascular Assessment of Proatherosclerotic Effects of Smoking (SUR – VAPES) 2 Randomized Trial. J Am Heart Assoc. 2019;8(6):e010455. doi:10.1161/JAHA.118.01045.
13.
Liu X, Lugo A, Spizzichino L, Tabuchi T, Pacifici R, Gallus S. Heat-not-burn tobacco products: concerns from the Italian experience. Tob Control. 2019;28(1):113–114. doi:10.1136/tobaccocontrol-2017-05405.
14.
Stone MD, DeAtley T, Pianin S, Strasser AA, Audrain-McGovern J. Switching from cigarettes to IQOS: A pilot examination of IQOS-associated reward, reinforcement, and abstinence relief. Drug Alcohol Depend. 2022;238:109569. doi:10.1016/j.drugalcdep.2022.109569.
15.
Concha-Lozano N, Jacot-Sadowski I, Cornuz J, Berthet A. Heat-Not-Burn Tobacco Cigarettes: Smoke by Any Other Name. JAMA Intern Med. 2017;177(7):1050–1052. doi:10.1001/jamainternmed.2017.1419.
16.
Lyytinen G, Melnikov G, Brynedal A, et al. Use of heated tobacco products (IQOS) causes an acute increase in arterial stiffness and platelet thrombus formation. Atherosclerosis. 2024;390:117335. doi:10.1016/j.atherosclerosis.2023.117335.
17.
Ikonomidis I, Vlastos D, Kostelli G, et al. Differential effects of heat-not-burn and conventional cigarettes on coronary flow, myocardial and vascular function. Sci Rep. 2021;11(1):11808. Published 2021 Jun 3. doi:10.1038/s41598-021-91245-9.
19.
Hu H, Sasaki N, Ogasawara T, et al. Smoking, Smoking Cessation, and the Risk of Hearing Loss: Japan Epidemiology Collaboration on Occupational Health Study. Nicotine Tob Res. 2019;21(4):481–488. doi:10.1093/ntr/nty026.
20.
Hu H, Nakagawa T, Honda T, et al. Heated tobacco products and circulating high-density lipoprotein cholesterol concentrations. Sci Rep. 2022;12(1):17385. Published 2022 Oct 17. doi:10.1038/s41598-022-22337-3.
21.
Stratton K, Shetty P, Wallace R, Bondurant S. Clearing the smoke: the science base for tobacco harm reduction--executive summary. Tob Control. 2001;10(2):189–195. doi:10.1136/tc.10.2.189 Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004;164(20):2206–2216. doi:10.1001/archinte.164.20.2206.
22.
Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004;164(20):2206–2216. doi:10.1001/archinte.164.20.2206.
23.
Moazed F, Chun L, Matthay MA, Calfee CS, Gotts J. Assessment of industry data on pulmonary and immunosuppressive effects of IQOS. Tob Control. 2018;27(Suppl 1):s20-s25. doi:10.1136/tobaccocontrol-2018-054296.
24.
Pataka A, Kotoulas S, Chatzopoulos E, et al. Acute Effects of a Heat-Not-Burn Tobacco Product on Pulmonary Function. Medicina (Kaunas). 2020;56(6):292. Published 2020 Jun 12. doi:10.3390/medicina56060292.
25.
Polosa R, Morjaria JB, Prosperini U, et al. Health outcomes in COPD smokers using heated tobacco products: a 3-year follow-up [published correction appears in Intern Emerg Med. 2022 Sep;17(6):1849]. Intern Emerg Med. 2021;16(3):687–696. doi:10.1007/s11739-021-02674-3.
26.
Loffredo L, Carnevale R, Pannunzio A, et al. Impact of heat-not-burn cigarette passive smoking on children’s oxidative stress, endothelial and platelet function. Environ Pollut. 2024;345:123304. doi:10.1016/j.envpol.2024.123304.
27.
Kassebaum NJ, Smith AGC, Bernabé E, et al. Global, Regional, and National Prevalence, Incidence, and Disability-Adjusted Life Years for Oral Conditions for 195 Countries, 1990–2015: A Systematic Analysis for the Global Burden of Diseases, Injuries, and Risk Factors. Journal of Dental Research. 2017;96(4):380–387. doi:10.1177/0022034517693566.
28.
Bergeron, E.-J., De la Stomatite ulcereuse des Soldats, Paris, Labe: p. 70, 1859.
29.
Pindborg JJ. Tobacco and Gingivitis. Journal of Dental Research. 1947;26(3):261–264. doi:10.1177/00220345470260030901.
30.
Yoshioka T, Tabuchi T. Combustible cigarettes, heated tobacco products, combined product use, and periodontal disease: A cross-sectional JASTIS study. PLoS One. 2021;16(3):e0248989. Published 2021 Mar 30. doi:10.1371/journal.pone.0248989.
31.
Mišković I, Kuiš D, Špalj S, Pupovac A, Prpić J. Periodontal Health Status in Adults Exposed to Tobacco Heating System Aerosol and Cigarette Smoke vs. Non-Smokers: A Cross-Sectional Study. Dent J (Basel). 2024;12(2):26. Published 2024 Jan 29. doi:10.3390/dj12020026.
32.
Millett C, Wen LM, Rissel C, Smith A, Richters J, Grulich A, de Visser R. Smoking and erectile dysfunction: findings from a representative sample of Australian men. Tob Control. 2006 Apr;15(2):136–9. doi:10.1136/tc.2005.015545. PMID: 16565463; PMCID: PMC2563576.
33.
Künzle R, Mueller MD, Hänggi W, Birkhäuser MH, Drescher H, Bersinger NA. Semen quality of male smokers and nonsmokers in infertile couples. Fertil Steril. 2003;79(2):287–291. doi:10.1016/s0015-0282(02)04664-2.
34.
Yoshida S, Ichinose T, Shibamoto T. Effects of Fetal Exposure to Heat-Not-Burn Tobacco on Testicular Function in Male Offspring. Biol Pharm Bull. 2020;43(11):1687–1692. doi:10.1248/bpb.b20-00390oi:10.1248/bpb.b20-00390.
35.
Granata S, Canistro D, Vivarelli F, et al. Potential Harm of IQOS Smoke to Rat Liver. Int J Mol Sci. 2023;24(15):12462. Published 2023 Aug 5. doi:10.3390/ijms241512462.
36.
Marques EA, Elbejjani M, Gudnason V, et al. Cigarette smoking and hip volumetric bone mineral density and cortical volume loss in older adults: The AGES-Reykjavik study. Bone. 2018;108:186–192. doi:10.1016/j.bone.2018.01.014.
37.
Egger P, Duggleby S, Hobbs R, Fall C, Cooper C. Cigarette smoking and bone mineral density in the elderly. J Epidemiol Community Health. 1996;50(1):47–50. doi:10.1136/jech.50.1.47.
38.
Xue J, Zhao Q, Sharma V, et al. Aryl Hydrocarbon Receptor Ligands in Cigarette Smoke Induce Production of Interleukin-22 to Promote Pancreatic Fibrosis in Models of Chronic Pancreatitis. Gastroenterology. 2016;151(6):1206–1217. doi:10.1053/j.gastro.2016.09.064.
39.
Weng W, Bovard D, Zanetti F, et al. Tobacco heating system has less impact on bone metabolism than cigarette smoke. Food Chem Toxicol. 2023;173:113637. doi:10.1016/j.fct.2023.113637.